2024 ICD-10-CM Diagnosis Code T82.7XXS

Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, sequela

ICD-10-CM Code:
T82.7XXS
ICD-10 Code for:
Infect/inflm react d/t oth cardi/vasc dev/implnt/grft, sqla
Is Billable?
Yes - Valid for Submission
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Complications of surgical and medical care, not elsewhere classified
      (T80-T88)
      • Complications of cardiac and vascular prosthetic devices, implants and grafts
        (T82)

T82.7XXS is a billable diagnosis code used to specify a medical diagnosis of infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, sequela. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

T82.7XXS is a sequela code, includes a 7th character and should be used for complications that arise as a direct result of a condition like infection and inflammatory reaction due to other cardiac and vascular devices implants and grafts. According to ICD-10-CM Guidelines a "sequela" code should be used for chronic or residual conditions that are complications of an initial acute disease, illness or injury. The most common sequela is pain. Usually, two diagnosis codes are needed when reporting sequela. The first code describes the nature of the sequela while the second code describes the sequela or late effect.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Abscess of cardiovascular heterograft
  • Abscess of cardiovascular homograft
  • Abscess of vascular cardiac conduit
  • Arteriovenous graft infection
  • Arteriovenous shunt infection
  • Bacteremia associated with intravascular line
  • Candidemia
  • Candidemia associated with intravascular line
  • Catheter related bloodstream infection
  • Complication associated with vascular implant
  • Complication associated with vascular implant
  • Complication of intravascular line
  • Complication of intravascular line
  • Complication of intravascular line
  • Complication of intravascular line
  • Complication of totally implantable venous access device
  • Disorder of arteriovenous shunt
  • Disorder of cardiac pacemaker electrode
  • Disorder of implanted defibrillator generator
  • Disorder of intra-aortic pulsation balloon
  • Endocarditis as complication of procedure
  • Fungemia
  • Implanted defibrillator electrode infection
  • Implanted defibrillator generator infection
  • Infected aortic graft
  • Infected aortofemoral graft
  • Infected aortoiliac graft
  • Infected arterial graft
  • Infected arterial graft
  • Infected arterial graft
  • Infected arterial graft
  • Infected arterial graft
  • Infected arterial graft
  • Infected arterial graft
  • Infected arterial graft
  • Infected arterial graft
  • Infected arterial graft
  • Infected axillofemoral graft
  • Infected femorodistal graft
  • Infected femorofemoral crossover graft
  • Infected femoropopliteal graft
  • Infected iliofemoral graft
  • Infected iliopopliteal graft
  • Infected pacemaker
  • Infection associated with biventricular automatic implantable cardioverter defibrillator
  • Infection associated with cardiac implant
  • Infection associated with cardiac implant
  • Infection associated with peritoneal dialysis catheter
  • Infection associated with totally implantable venous access device
  • Infection associated with vascular device
  • Infection associated with vascular implant
  • Infection of arteriovenous graft for hemodialysis
  • Infection of biventricular cardiac pacemaker
  • Infection of bloodstream co-occurrent and due to hemodialysis catheter in situ
  • Infection of bloodstream co-occurrent and due to temporary hemodialysis catheter in situ
  • Infection of bloodstream co-occurrent and due to tunneled hemodialysis catheter in situ
  • Infection of cardiac graft
  • Infection of catheter exit site
  • Infection of catheter exit site
  • Infection of catheter exit site
  • Infection of central venous catheter exit site
  • Infection of hemodialysis catheter
  • Infection of hemodialysis catheter exit site
  • Infection of hemodialysis temporary catheter
  • Infection of hemodialysis tunneled catheter
  • Infection of intravenous catheter
  • Infection of pacemaker pulse generator site
  • Infection of peritoneal dialysis catheter
  • Infection of tunnel site of tunneled central venous catheter
  • Infection of vascular catheter
  • Infection of vascular catheter
  • Infective endocarditis at site of implanted vascular shunt
  • Infective endocarditis of vascular cardiac conduit
  • Inflammation associated with cardiac implant
  • Inflammation associated with vascular device
  • Inflammation associated with vascular implant
  • Intra-aortic balloon infection
  • Line sepsis associated with dialysis catheter
  • LVAD driveline infection
  • Pacemaker electrode infection
  • Peritoneal dialysis catheter exit site infection
  • Peritoneal dialysis catheter tunnel infection
  • Sepsis associated with internal vascular access
  • Vascular graft infection

Clinical Classification

Clinical Information

  • Candidemia

    a form of invasive candidiasis where species of candida are present in the blood.
  • Fungemia

    the presence of fungi circulating in the blood. opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.
  • Candida

    a genus of yeast-like mitosporic saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. it is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including candidiasis; onychomycosis; vulvovaginal candidiasis; and candidiasis, oral (thrush).
  • Fungemia

    a laboratory test result indicating the presence of fungi or yeasts in the blood.
  • Fungemia, CTCAE|Fungemia

    a disorder characterized by the presence of fungus in the blood stream.
  • Grade 2 Fungemia, CTCAE|Grade 2 Fungemia

    moderate symptoms; medical intervention indicated
  • Grade 3 Fungemia, CTCAE|Grade 3 Fungemia

    severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated

Coding Guidelines

The appropriate 7th character is to be added to each code from block Complications of cardiac and vascular prosthetic devices, implants and grafts (T82). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Present on Admission (POA)

T82.7XXS is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA IndicatorReason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert T82.7XXS to ICD-9-CM

  • ICD-9-CM Code: 909.3 - Late eff surg/med compl
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.